Oral care compositions and methods
Provided herein is a pharmaceutical or oral care product for treating or preventing oral diseases that is prepared with proteoglycan 4 (PRG4) as an active ingredient, the preparing method thereof and the use thereof in manufacturing medicaments or oral care products for treating or preventing oral diseases and maintenance of oral health. PRG4 may have efficacy in maintaining oral health and treating or preventing oral disease. This secreted glycoprotein, which is also called lubricin and superficial zone protein, is known to protect against frictional forces, cell adhesion and protein deposition.
1. A method for treating an individual having a dental disease or condition selected from the group consisting of dental caries, tooth discoloration, periodontal disease, and pellicle layer reduction, the method comprising administering to an oral cavity of said individual a composition comprising a proteoglycan 4 (PRG4) protein comprising the amino acid sequence of SEQ ID NO:1 less amino acid residues 1-24, wherein said composition is administered in a therapeutically effective amount sufficient to treat said disease or condition.
2. The method of claim 1 , wherein the disease or condition is periodontal disease.
3. The method of claim 1 , wherein said PRG4 protein is suspended in an orally acceptable solution.
4. The method of claim 1 , wherein the administering to the oral cavity of said individual is by topical application to one or more teeth of the individual.
5. The method of claim 1 , wherein the administering to the oral cavity of said individual is by topical application to a soft tissue of the oral cavity.
6. The method of claim 5 , wherein the soft tissue is the gums.
7. The method of claim 1 , wherein the administering to the oral cavity of said individual is by a mouth wash or rinse solution.
8. The method of claim 1 , wherein the administering to the oral cavity of said individual is by a gel, a powder, a spray, a chewing gum, or a dissolvable tablet.
9. The method of claim 1 , wherein the effective amount is between 10 μg/mL and 10,000 μg/mL.
10. The method of claim 1 , wherein the effective amount is between 50 μg/mL and 5,000 μg/mL.
11. The method of claim 1 , wherein the effective amount is between 100 μg/mL and 300 μg/mL.
12. The method of claim 1 , wherein the PRG4 protein has an average molar mass between 50 kDa and 400 kDa.
13. The method of claim 1 , wherein the composition further comprises an oral care active selected from the group consisting of teeth color modifying substances, anti-tartar agents, anti-plaque agents, fluoride ion sources, anti-microbial agents, peroxides, polyphosphates, xylitol, triclosan, stannous fluoride, soluble zinc salts, potassium nitrate, and mixtures thereof.
14. The method of claim 13 , wherein the composition comprises from about 0.01% to about 20% by weight of the oral care active.
15. The method of claim 1 , wherein the composition further comprises a surface active phospholipid.
16. The method of claim 15 , wherein the surface active phospholipid is selected from the group consisting of L-α-dipalmitoylphosphatidylcholine, phosphatidylcholine, phosphatidylethanolamine, and sphingomyelin.
17. The method of claim 1 , wherein the composition further comprises an effective amount of sodium hyaluronate or hyaluronic acid.